Showing posts with label Donald L. Trump MD. Show all posts
Showing posts with label Donald L. Trump MD. Show all posts

Sunday, December 11, 2011

When Is a Headache More Than Just a Headache?

What would cause a 34-year-old woman to waken with severe and throbbing head pain, nausea and dizziness?  A 9-year-old to have a headache lasting four months? Or an otherwise healthy 32-year-old woman to have severe headaches and seizures?

These are just some of the difficult cases of severe headache pain the DENT Neurological Institute sees every day.

Laszlo Mechtler, M.D.,
Director of DENT’s Headache Center and President elect of the American Society of Neuroimaging, says, “Most of the people we see have primary headache disorders, such as migraine and tension type headaches. A common medical complaint, they are experienced by 75% of the population with over 5% seeking medical aid. In fact, about 16% of emergency room (ER) visits are attributable to headache complaints.”

Mechtler explains, “Patients who are the most complex are those where headaches come from a secondary cause, which includes more than 316 life-threatening disorders and illnesses. They are the toughest cases, and neuroimaging studies are required to determine the underlying cause.” Some of the key symptoms or red flags that help clinicians determine if further studies are needed include:

·   First or worst headache, onset of headaches after age 50, following head trauma, or in someone with cancer or HIV
·   Chronic daily headaches unresponsive to treatment or headaches with increased frequency and severity
·   Headaches always on the same side, or following exertion, strain or positional changes
·   Headaches accompanied by fever, stiff neck, rash, atypical aura, abnormal neurological exam or seizures

Of adults with headache seen in the ER, only 16-20% have secondary headaches, as compared with 77% of children. Of these children 45% suffer from secondary headaches due to neurological causes. Red flags in children differ from adult warning signs and include:

·   Persistent headaches that last less than 6 months but don’t respond to treatment
·   Headaches that awaken the child from sleep or occur when awakening or with episodes of confusion or disorientation
·   Family and/or medical history of central nervous system involvement or abnormal neurological test results

DENT is home to the only Headache Center in Western New York where more than 17,000 patients are seen yearly. In fact, the only other centers within reasonable traveling distance are located in Cleveland, New York City and Philadelphia. Trained staff at the Center include physicians who are board certified in neurology, neuroimaging, and  neuro-oncology supported by physician assistants, nurse practitioners, psychiatrists, nurses and clinical research staff.  Research and education are ongoing, as are new treatments and medications unavailable anywhere else. An onsite infusion lab and Urgent Care Center assures that patients can be seen 24/7. Meanwhile, Dr. Mechtler says, “About 120,000 people in our region suffer from migraines, but only 15% receive treatment. To learn more about headaches visit www.headache-advisor.com.

WNY Resource:

DENT Headache Center
716-250-2000
www.dentinstitute.com


Saturday, December 10, 2011

ROSWELL PARK WILL LEAD $5.1M GENE-SEQUENCING EFFORT FUNDED BY NYS INITIATIVE


Effort will examine genetic factors in common diseases and advance field of personalized medicine

BUFFALO, NY — The Roswell Park Cancer Institute Genome Project was approved December 8, 2011 as part of Gov. Andrew Cuomo’s Regional Economic Development Council initiative. RPCI will lead this project, which will compile and analyze the detailed genetic data (the “genomes”) of Western New York citizens. This will significantly enhance our ability to develop personalized, more effective medical care plans and treatments for citizens of Western New York (WNY) — and beyond.
The $5.1 million award for the RPCI Genome Project covers the two-year pilot phase of the project. During this phase of the project, 1,000 area residents will be asked to donate a blood sample and provide detailed medical information; all these data will be collected in a fully protected way to ensure the privacy of all participants. The Genome Project will examine genetic factors that play a role in cancer as well as common diseases such as diabetes, heart disease and hypertension.
RPCI President and CEO Donald L. Trump, MD, FACP, and Deputy Director Candace Johnson, PhD, will lead the RPCI Genome Project as Co-Principal Investigators. Partners include the University at Buffalo, Kaleida Health, the Catholic Health System and Erie County Medical Center as well as the three major health insurers in WNY (HealthNow/BlueCross BlueShield, Independent Health and Univera Healthcare), The P2 Collaborative and HEALTHeLINK.
The Roswell Park Cancer Institute Genome Project was championed by WNY Regional Economic Development Council (WNYREDC) Co-Chairs Satish K. Tripathi, University at Buffalo President, and Howard A. Zemsky, Managing Partner of Larkin Development Group, along with Andrew Rudnick, President of the Buffalo Niagara Partnership and Health & Life Sciences Co-Chair for the WNYREDC.
“Together, they ably and energetically oversaw the maturation and development of this proposal, working closely with RPCI at every stage,” said Dr. Trump. “We are grateful for the leadership they, Governor Cuomo and all the members of the Western New York Regional Council have provided through this ambitious development program, and eagerly look forward to implementing this effort.”
For more information, visit RPCI’s website athttp://www.roswellpark.org, call 1-877-ASK-RPCI (1-877-275-7724) or email askrpci@roswellpark.org.